Feasibility of sentinel lymph node biopsy in multifocal/multicentric breast cancer

Chang Gung Medical Journal

Volumn 32, Issue 1, 2009, Pages 51-58

  Lo, Yung Feng ^a   Cheung, Yun Chung ^a   Hsueh, Swei ^a   Ho, Kung Chu ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Breast cancer; Multifocal multicentric; Sentinel lymph node

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TRACER;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEASIBILITY STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CANCER; PREOPERATIVE EVALUATION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 60549098637     PISSN: 20720939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Andea AA, Wallis T, Newman LA, Bouwman D, Dey J, Visscher DW. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer 2002;94:1383-90.
2. Coombs NJ, Boyages J. Multifocal and multicentric breast cancer: does each focus matters? J Clin Oncol 2005;23:7497-502.
3. Kinne DW. Controversies in primary breast cancer management. Am J Surg 1993;166:502-8.
4. Anastassiades O, Iakovou F, Stravridou N, Gogas J, Karameris A. Multicentricity in breast cancer. Am J Clin Pathol 1993;99:238-43.
5. Egan RL. Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer 1982;49:1123-30.
6. Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, Glass EC, Tyrner RR. Prospective observational study of sentinel lymphadenectomy without axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18:2553-9.
7. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53.
8. Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, Port E, Sacchini V, Sclafani L, VanZee K, Wagman R, Borgen PI, Cody HS. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection. Ann Surg 2004;240:462-71.
9. Mateos JJ, Vidal-Sicart S, Zanón G, Pahisa J, Fuster D, Martín F, Ortega M, Fermá P, Pons F. Sentinel lymph node biopsy in breast cancer patients: subdermal versus peritumoural radiocolloid injection. Nucl Med Commun 2001;22:17-24.
10. McMasters KM, Wong SL, Martin II RCG, Chao C, Tuttle TM, Noyes RD, Carlson DJ, Laidley AL, McGlothin TQ, Ley PB, Brown CM, Glaser RL, Pennington RE, Turk PS, Simpson D, Cerrito PB, Edwards MJ. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 2001;233:676-87.
11. Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS 3rd, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP. American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-20.
12. Lo YF, Hsueh S, Ma SY, Chen SC, Chen MF. Radioguided sentinel lymph node biopsy in early breast cancer: experience at Chang Gung Memorial Hospital. Chang Gung Med J 2006;29:458-67.
13. Pinder SE, Murray S, Ellis IO, Trihia H, Elston CW, Gelber RD, Goldhirsch A, Lindtner J, Cortés-Funes H, Simoncini E, Byrne MJ, Golouh R, Rudenstam CM, Castiglione-Gertcsh M, Gusterson BA. The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer 1998;83:1529-39.
14. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, De Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7.
15. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, Robertson C, Sacchini V, Veronesi P, Orvieto E, De Cicco C, Intra M, Tosi G, Scarpa D. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368-73.
16. Knauer M, Konstantiniuk P, Haid A, Wenzl E, Riegler-Keil M, Pöstlberger S, Reitsamer R, Schrenk P. Multicentric breast cancer: a new indication for sentinel node biopsy- a multi-institutional validation study. J Clin Oncol 2006;24:3374-80.
17. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. A meta-analysis. Cancer 2005; 106:4-16.
18. Ozmen V, Muslumanoglu M, Cabioglu N, Tuzlali S, Ilhan R, Igci A, Kecr M, Bozfakioglu Y, Dagoglu T. Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer. Breast Cancer Res Treat 2002;76:237-44.
19. Layeeque R, Henry-Tillman R, Korourian S, Kass R, Klimberg S. Subareolar sentinel node biopsy for multiple breast cancers. Am J Surg 2003;186:730-6.
20. Kim HJ, Heerdt AS, Cody HSIII, Van Zee KJ. Sentinel lymph node drainage in multicentric breast cancers. Breast J 2002;8:356-61.
21. Bergkvist L, Frisell J. Multicentre validation study of sentinel node biopsy for staging in breast cancer. Br J Surg 2005;92:1221-4.
22. Klimberg VS, Rubio IT, Henry R, Cowan C, Colvert M, Korourian S. Subareolar versus peritumoral injection for localization of the sentinel lymph node. Ann Surg 1999;229:860-5.
23. Tousimis E, Zee KJV, Fey JV, Hoque LW, Tan LK, Cody HSIII, Borgen PI, Montgomery LL. The accuracy of sentinel lymph node biopsy in multicentric and nultifocal invasive breast cancers. J Am Coll Surg 2003;197:529-35.
24. Schrenk P, Wayand W. Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer. Lancet 2001;357:122.
25. Kumar R, Jana S, Heiba SI, Dakhel M, Axelrod D, Siegel B, Bernik S, Mills C, Wallack M, Abdel-Dayem HM. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable,or nonpalpable breast cancer. J Nucl Med 2003;44:7-10.
26. Goyal A, Newcombe RG, Mansel RE. Sentinel lymph node biopsy in patients with multifocal breast cancer. Eur J Surg Oncol 2004;30:475-9.
27. Kumar R, Potenta S, Alavi A. Sentinel lymph node biopsy in multifocal and multicentric breast cancer. J Am Coll Surg 2004;198:674-6.
28. Gentilini O, Trifirò G, Soteldo J, Luini A, Intra M, Galimberti V, Veronesi P, Silva L, Gandini S, Paganelli G, Veronesi U. Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of Oncology. Eur J Surg Oncol 2006;32:507-10.
29. Hill ADK, Tran KN, Akhurst T, Yeung H, Yeh SDJ, Rosen PP, Borgen PI, Cody HS III. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999;229:528-35.